Correction : BMC Bioinformatics (2023) 24:270 10.1186/s12859-023-05391-0
Following the publication of the original article [1], the authors identified that the funding statement was incorrect. The correct Funding is given below.
The incorrect funding is: This work was supported by the National Natural Science Foundation of China (Grant No. 81960525 and 82160591), Science and the Technology Commission of Shanghai Municipality (Grant No. 19DZ1930900), The Top-level Clinical Discipline Project of Shanghai Pudong (PWYgf2021-07), Key Project of Clinical Research of Shanghai East Hospital, Tongji University (Grant No. DFLC2022012) and Key Specialty Construction Project of Shanghai Pudong New Area Health Commission (Grant No. PWZzk2022-02).
The correct funding is: This work was supported by the National Natural Science Foundation of China (Grant No. 81960525 and 82160591), Science and the Technology Commission of Shanghai Municipality (Grant No. 19DZ1930903), The Top-level Clinical Discipline Project of Shanghai Pudong (PWYgf2021-07), Key Project of Clinical Research of Shanghai East Hospital, Tongji University (Grant No. DFLC2022012) and Key Specialty Construction Project of Shanghai Pudong New Area Health Commission (Grant No. PWZzk2022-02).
The original article [1] has been corrected.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Xue-Qin Chen and Jie Ma have contributed equally to this work and share first authorship
Reference
- 1.Chen, et al. Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinoma. BMC Bioinformatics. 2023;24:270. doi: 10.1186/s12859-023-05391-0. [DOI] [PMC free article] [PubMed] [Google Scholar]